Plasma Fractionation Market to Reach $30.53 Bn, Globally, by 2028 at 6.1% CAGR: Allied Market Research

News provided by

Jan 13, 2020, 08:50 ET

PORTLAND, Oregon, Jan. 13, 2020 /PRNewswire/ -- Allied Market Research published a report, titled, "Plasma Fractionation Market by Product (Albumin, Immunoglobulins, and Coagulation Factor VIII), Application (Neurology, Hematology, Immunology, Critical Care and Others), End User (Hospitals, and Research Laboratories): Global Opportunity Analysis and Industry Forecast, 2018–2028." According to the report, the global plasma fractionation market garnered $16.82 billion in 2018, and is estimated to reach $30.53 billion by 2028, growing at a CAGR of 6.1% from 2019 to 2028.

Drivers, restraints, and opportunities

Increase in geriatric population, surge in prevalence of rare diseases, rise in usage of immunoglobulins in areas of medicine, and upsurge in number of plasma collection centers drive the growth of the global plasma fractionation market. However, high cost of plasma-derived products hinders the market growth. On the other hand, potential for growth in emerging countries create new opportunities in the market.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/943

The immunoglobulins segment to maintain its lead position during the forecast period

Based on product, the immunoglobulins segment contributed to more than two-thirds of the total share of the global plasma fractionation market in 2018, and is expected to maintain its lead position during the forecast period. Moreover, this segment is estimated to register the largest CAGR of 6.7% from 2019 to 2028. This is due to increase in recognition and treatment of immune deficiencies along with rise in the usage of high dose IgG products in the treatment of autoimmune neurologic diseases. The research also discusses segments such as albumin and coagulation factor VIII.

The neurology segment to maintain its leadership position during the forecast period

Based on application, the neurology segment held the highest market share of the global plasma fractionation market, accounting for more than two-fifths of the total share in 2018, and is estimated to maintain its leadership position in terms of revenue during the forecast period. Moreover, this segment is estimated to grow at the highest rate with a CAGR of 6.8% from 2019 to 2028. This is due to increase in awareness related to diagnosis and treatment of neurological disorders in animals. The research also analyzes segments including hematology, immunology, critical care, and others.

China (including Taiwan) to present lucrative opportunities

Based on country, China (including Taiwan) contributed to the highest market share in terms of revenue, contributing to nearly one-fifth of the global plasma fractionation market in 2018, and is expected to maintain its dominance in terms of revenue during the forecast period. This country is expected to maintain the largest CAGR of 9.2% from 2019 to 2026, owing to huge patient base of disorders such as hemophilia, Von Willebrand disease, and others along with rise in awareness related to blood donations.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/943

Leading market players

Grifols SA
Baxter International Inc.
CSL LTD.
Bio Product Laboratory
Octapharma AG
Sanquin
Laboratoire Franais Du Fractionnement Et Des
Kedrion
Biotest
Takeda Pharmaceuticals

Access KNOWLEDGE TREE (Premium on-demand, subscription-based pricing model) at: https://www.alliedmarketresearch.com/knowledgetree

Knowledge tree is a cloud-based intelligence platform that offers more than 2,000 selective, off-the-shelf reports on niche markets to enable our clients gain deep insights on the latest trends, dynamic technologies, and emerging application areas.

Get Up to 30% Discount on All Published Reports:

Albumin Market - Global Opportunity Analysis and Industry Forecast, 2016-2023

Blood Plasma Derivatives Market - Global Opportunity Analysis and Industry Forecast, 2016-2023

Immunoglobulin Market: Global Opportunity Analysis and Industry Forecast, 2018 - 2025

Pre-Book Now with 12% Discount:

Cold Plasma Market - Global Opportunity Analysis and Industry

Home Care Monitoring and Diagnostics Market - Global Opportunity Analysis and Industry

Hydrocolloid Dressing Market - Global Opportunity Analysis and Industry

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]
Web: www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research
Follow Us on Twitter: https://twitter.com/marketresearcht